President and CEO of Zimmer Biomet Holdings Inc (ZBH, Financial) Bryan C Hanson bought 2,100 shares of ZBH on 02/07/2019 at an average price of $119.02 a share. The total cost of this purchase was $249,942.
Zimmer Biomet Holdings Inc is a medical device company. It designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery under brands like NexGen, Persona, Zimmer, and Polaris. Zimmer Biomet Holdings Inc has a market cap of $24.6 billion; its shares were traded at around $120.58 with a P/E ratio of 14.05 and P/S ratio of 3.12. The dividend yield of Zimmer Biomet Holdings Inc stocks is 0.80%. Zimmer Biomet Holdings Inc had annual average EBITDA growth of 0.80% over the past ten years.
CEO Recent Trades:
- President and CEO Bryan C Hanson bought 2,100 shares of ZBH stock on 02/07/2019 at the average price of $119.02. The price of the stock has increased by 1.31% since.
Directors and Officers Recent Trades:
- Director Maria Teresa Hilado bought 1,650 shares of ZBH stock on 02/07/2019 at the average price of $118.18. The price of the stock has increased by 2.03% since.
- Director Christopher B Begley bought 2,540 shares of ZBH stock on 02/06/2019 at the average price of $117.19. The price of the stock has increased by 2.89% since.
- Director Betsy J Bernard bought 4,250 shares of ZBH stock on 02/06/2019 at the average price of $117.41. The price of the stock has increased by 2.7% since.
- Director Gail Boudreaux bought 2,095 shares of ZBH stock on 02/05/2019 at the average price of $119.33. The price of the stock has increased by 1.05% since.
- Director Robert Hagemann bought 2,000 shares of ZBH stock on 02/05/2019 at the average price of $119.83. The price of the stock has increased by 0.63% since.
For the complete insider trading history of ZBH, click here
.
